Related Experiment Video
Updated: Aug 12, 2026
10:53
Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Hypokalemia from beta 2-receptor stimulation by circulating epinephrine
The American Journal of Cardiology
|August 30, 1985
Summary
Beta 2-receptor stimulation causes hypokalemia, which is not influenced by insulin or aldosterone. Selective beta 2 blockade prevents this condition without affecting epinephrine's inotropic effect.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Catecholamines can induce hypokalemia.
- The precise mechanisms behind this effect require further elucidation.
Purpose of the Study:
- To investigate the role of beta 2-receptor stimulation in catecholamine-induced hypokalemia.
- To determine if insulin, renin, or aldosterone mediate this effect.
- To assess the efficacy of selective beta 2 blockade in preventing catecholamine-induced hypokalemia.
Main Methods:
- Utilized beta 2-receptor blockade as a selective intervention.
- Administered epinephrine to induce hypokalemia.
- Monitored potassium levels and cardiac inotropic effects.
Main Results:
- Beta 2-receptor stimulation is essential for catecholamine-induced hypokalemia.
- This hypokalemia is independent of insulin, renin, and aldosterone.
- Selective beta 2 blockade effectively prevented hypokalemia.
- The inotropic effect of epinephrine remained intact following beta 2 blockade.
Conclusions:
- Beta 2-receptors are critical mediators of catecholamine-induced hypokalemia.
- Pharmacological blockade of beta 2-receptors offers a targeted approach to prevent this electrolyte imbalance.
- Therapeutic strategies targeting beta 2-receptors may be beneficial in managing conditions associated with catecholamine excess.
More Related Videos
Related Concept Videos
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...